Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
A study of the effect of the early treatment with Pulmicort of newly diagnosed asthma. Patients will receive either Pulmicort or a non-active treatment for three years. Neither patients or investigators will be aware of the treatment received. After three years of treatment all patients will receive Pulmicort for 2 further years.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
6 Years to 60 Years (Child, Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Male or female patients aged between 6 and 60 years
diagnosed with asthma within 2 years of starting the study
Ability to use a Turbuhaler
Symptoms indicating asthma (e.g. wheezing) for more than two years prior to starting the study
A history of the use of treatments like Pulmicort for more than 30 days per year in the two years before starting the study
Regular daily treatment for asthma for more than two years before starting the study